PPARG and melanoma: Further evidence reveals that PPAR-γ activation reduces TXNIP expression in human melanoma cells (A375 and C8161), affecting the expression of proteins of particular relevance to melanoma cell invasiveness, such as integrin alpha-v/beta-3 and TIMP-2, resulting in melanoma progression to a metastatic phenotype [56].